Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sridhar Mani

Showing results (51-60 of 170) with videos related to

Pageof 17
Sort By:
Anti-Cancer Drugs|June 19, 2004
The clinical development of new mitotic inhibitors that stabilize the microtubuleSridhar Mani, Manuel Macapinlac, Sanjay Goel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical studyHayley M McDaid, Sridhar Mani, Heng-Jia Shen, et al.
Investigational New Drugs|September 8, 2006
Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinomaMinaxi Jhawer, Lee Rosen, Janet Dancey, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2013
Chrysin ameliorates chemically induced colitis in the mouse through modulation of a PXR/NF-κB signaling pathwayWei Dou, Jingjing Zhang, Eryun Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Activation of the steroid and xenobiotic receptor (human pregnane X receptor) by nontaxane microtubule-stabilizing agentsSridhar Mani, Haiyan Huang, Sumathy Sundarababu, et al.
Molecular Cancer Therapeutics|December 14, 2002
Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathwaysKongming Wu, Chenguang Wang, Mark D'Amico, et al.
Investigational New Drugs|August 5, 2004
Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumorsSamir D Undevia, Nicholas J Vogelzang, Ann M Mauer, et al.
Investigational New Drugs|June 10, 2006
Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282Minaxi Jhawer, Sridhar Mani, Myrto Lefkopoulou, et al.
Pharmaceutical Biology|September 4, 2020
Obacunone reduces inflammatory signalling and tumour occurrence in mice with chronic inflammation-induced colorectal cancerXiaoping Luo, Zhilun Yu, Bei Yue, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 20, 2020
Early Life Exposure to Environmental Contaminants (BDE-47, TBBPA, and BPS) Produced Persistent Alterations in Fecal Microbiome in Adult Male MiceMatthew V Gomez, Moumita Dutta, Alexander Suvorov, et al.
Pageof 17

Showing results (51-60 of 170) with videos related to

Sort By:
Pageof 17
Anti-Cancer Drugs|June 19, 2004
The clinical development of new mitotic inhibitors that stabilize the microtubuleSridhar Mani, Manuel Macapinlac, Sanjay Goel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical studyHayley M McDaid, Sridhar Mani, Heng-Jia Shen, et al.
Investigational New Drugs|September 8, 2006
Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinomaMinaxi Jhawer, Lee Rosen, Janet Dancey, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2013
Chrysin ameliorates chemically induced colitis in the mouse through modulation of a PXR/NF-κB signaling pathwayWei Dou, Jingjing Zhang, Eryun Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Activation of the steroid and xenobiotic receptor (human pregnane X receptor) by nontaxane microtubule-stabilizing agentsSridhar Mani, Haiyan Huang, Sumathy Sundarababu, et al.
Molecular Cancer Therapeutics|December 14, 2002
Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathwaysKongming Wu, Chenguang Wang, Mark D'Amico, et al.
Investigational New Drugs|August 5, 2004
Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumorsSamir D Undevia, Nicholas J Vogelzang, Ann M Mauer, et al.
Investigational New Drugs|June 10, 2006
Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282Minaxi Jhawer, Sridhar Mani, Myrto Lefkopoulou, et al.
Pharmaceutical Biology|September 4, 2020
Obacunone reduces inflammatory signalling and tumour occurrence in mice with chronic inflammation-induced colorectal cancerXiaoping Luo, Zhilun Yu, Bei Yue, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 20, 2020
Early Life Exposure to Environmental Contaminants (BDE-47, TBBPA, and BPS) Produced Persistent Alterations in Fecal Microbiome in Adult Male MiceMatthew V Gomez, Moumita Dutta, Alexander Suvorov, et al.
Pageof 17